DrugPatentWatch Database Preview

Litigation Details for INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND v. CELGENE CORPORATION (D.N.J. 2014)

« Back to Dashboard

INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND v. CELGENE CORPORATION (D.N.J. 2014)

Docket		Date Filed	2014-11-07
Court	District Court, D. New Jersey	Date Terminated
Cause	15:1 Antitrust Litigation	Assigned To	Madeline Cox Arleo
Jury Demand	Plaintiff	Referred To	Michael A. Hammer
Parties	CELGENE CORPORATION; CITY OF PROVIDENCE; DAVID MITCHELL; INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND; INTERNATIONAL UNION OF OPERATING ENGINEERS STATIONARY ENGINEERS LOCAL 39 HEALTH AND WELFARE TRUST FUND; NEW ENGLAND CARPENTERS HEALTH BENEFITS FUND; THALOMID AND REVLIMID ANTITRUST LITIGATION C.A. NO. 2:14-CV-06997-KSH-CLW; THE DETECTIVES' ENDOWMENT ASSOCIATION, INC.
Patents	5,635,517; 6,045,501; 6,281,230; 6,315,720; 6,555,554; 6,561,976; 6,561,977; 6,755,784; 7,119,106; 7,465,800; 8,288,415; 8,315,886; 8,404,717
Attorneys	CHRISTOPHER MICHAEL RUSSO; DANIEL B. REHNS; ERICA G. LANGSEN; JEFFREY B. GITTLEMAN; JOHN ANTHONY BLYTH; KATIE ROSE BERAN; NICOLE DENISE BEARCE; WHITNEY ERIN STREET
Firms	Counsel Not Admitted to Usdc-Nj Bar, Block & Leviton LLP; Gardy & Notis LLP; Hach Rose Schirripa & Cheverie, LLP; Hausfeld LLP PA; Lowenstein Sandler
Link to Docket	External link to docket

Details for INTERNATIONAL UNION OF BRICKLAYERS AND ALLIED CRAFT WORKERS LOCAL 1 HEALTH FUND v. CELGENE CORPORATION (D.N.J. 2014)

Date Filed	Document No.	Description	Snippet	Link To Document
2014-11-07	1		Revlimid (including patent numbers 5,635,517 (the “’517 patent”), 6,281,230 (the “’230 patent”), 6,555,554 …manufacturer’s patents and patent information for accuracy or trustworthiness. In listing patents and patent information…6,315,720 patent, the 6,561,976 patent, the 6,561,977 patent and the 6,755,784 patent (the “Distribution Method…information describing the patent as a “drug product patent” only if the patent claimed the drug product…Method Patents”), and the 8,315,886 patent. The chronological history of these patents is as follows:	External link to document
2015-02-03	20	Brief	Complaint, IUB only explicitly labels U.S. Patent Nos. 6,045,501, 6,315,720, 6,651,976, 6,561,977, and …three dozen patents, other than the six Distribution Method patents, in its broad patent portfolio covering… Method Patents (Compl. ¶¶ 123-210) – the patent examiner would not have issued the patent claim. See…liable for asserting its patents to preclude generic competition unless the patents in … other patents covering Revlimid and Thalomid were the subject of either fraud on the patent office	External link to document
2015-10-29	68		five Distribution Patents, along with Patent No. 5,635,517 (“the ’517 Patent”), Patent No. 6,281,230 (…Revlimid: Patent No. 6,045,501 (“the ’501 Patent”); Patent No. 6,315,720 (“the ’720 Patent”); Patent No. …’976 Patent”); Patent No. 6,561,977 (“the ’977 Patent”); Patent No. 6,755,784 (“the ’784 Patent”); and…230 Patent”), Patent No. 6,555,554 (“the ’554 Patent”), Patent No. 7,119,106 (“the ’106 Patent”), and…obtained: the ’720 Patent in 2001; the ’976 Patent and ’977 Patent in 2003; and the ’784 Patent in 2004. (Id	External link to document